Related references
Note: Only part of the references are listed.Criteria for evaluation of disease extent by 123I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force
K. K. Matthay et al.
BRITISH JOURNAL OF CANCER (2010)
Whole-body MRI of neuroblastoma
Hyun Woo Goo
EUROPEAN JOURNAL OF RADIOLOGY (2010)
123I-Meta-Iodobenzylguanidine Scintigraphy for the Detection of Neuroblastoma and Pheochromocytoma: Results of a Meta-Analysis
Arnold F. Jacobson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century
Malcolm A. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma
Brian H. Kushner et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Comparison of Iodine-123 Metaiodobenzylguanidine (MIBG) Scan and [18F]Fluorodeoxyglucose Positron Emission Tomography to Evaluate Response After Iodine-131 MIBG Therapy for Relapsed Neuroblastoma
Denah R. Taggart et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
123I-MIBG Scintigraphy and 18F-FDG PET in Neuroblastoma
Susan E. Sharp et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
123I-mIBG Scintigraphy in Patients With Known or Suspected Neuroblastoma: Results From a Prospective Multicenter Trial
Terry A. Vik et al.
PEDIATRIC BLOOD & CANCER (2009)
Utility of FDG-PET/CT in the Follow-Up of Neuroblastoma Which Became MIBG-Negative
Heather Mc Dowell et al.
PEDIATRIC BLOOD & CANCER (2009)
The prognostic impact of functional imaging with 123I-mIBG in patients with stage 4 neuroblastorna >1 year of age on a high-risk treatment protocol:: Results of the German Neuroblastoma Trial NB97
Matthias Schmidt et al.
EUROPEAN JOURNAL OF CANCER (2008)
Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology
J. Stauss et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Utility of FDG-PET/CT in the Follow-Up of Neuroblastoma Which Became MIBG-Negative
Cecile Colavolpe et al.
PEDIATRIC BLOOD & CANCER (2008)
Integrated imaging using MRI and 123I metaiodobenzylguanidine scintigraphy to improve sensitivity and specificity in the diagnosis of pediatric neuroblastoma
T Pfluger et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2003)
Guidelines for radioiodinated MIBG scintigraphy in children
P Olivier et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2003)
Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy
BH Kushner et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Applications of nuclear medicine in pediatric oncology
LP Connolly et al.
CLINICAL NUCLEAR MEDICINE (2002)
Survival of children with neuroblastoma: time trends and regional differences in Europe, 1978-1992
C Spix et al.
EUROPEAN JOURNAL OF CANCER (2001)
Share Paper
